ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00516724
Recruitment Status : Active, not recruiting
First Posted : August 15, 2007
Last Update Posted : February 28, 2018
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : January 4, 2013
  Estimated Study Completion Date : December 28, 2018